期刊文献+

犬尿素通路在氯胺酮抗抑郁中的作用 被引量:2

Role of kynurenine pathway in the antidepressant effects of ketamine
下载PDF
导出
摘要 目的 观察氯胺酮抗抑郁症过程中大鼠海马IL-1β、吲哚胺2,3-二加氧酶(IDO)、色氨酸(TRP)、犬尿素(KYN)的变化,探讨犬尿素通路在氯胺酮抗抑郁机制中的作用.方法 雄性Wistar大鼠18只,200~250 g,随机均分为三组:抑郁组(D组)、氯胺酮组(K组)和对照组(C组).D组和K组经过21 d慢性不可预知应激试验,建立大鼠慢性抑郁模型.第22天分别腹腔注射相同容积生理盐水(C组和D组)或氯胺酮10 mg/kg(K组),给药后30 min强迫游泳6 min,记录后5 min不动时间.行为学测试后,取大鼠海马组织,采用ELISA法测定IL-lβ、IDO、TRP及KYN的含量.结果 与C组比较,D组和K组强迫游泳不动时间明显增多(P<0.05或P<0.01),D组IL-1β、IDO含量及KYN/TRP比值明显升高(P<0.05).与D组比较,K组强迫游泳不动时间明显减少(P<0.0l),IL-1β、IDO含量及KYN/TRP比值明显降低(P<0.05);C组与K组差异无统计学意义.结论 氯胺酮可通过下调KYN通路发挥抗抑郁作用. Objective To observe the changes of hippocampal levels of IL-1β,IDO,tryptophan (TRP),kynurenine (KYN) during ketamine's antidepressant effects in rats,and explore the role of kynurenine pathway.Methods A total of 18 male Wistar rats (200-250 g) were randomly divided into 3 groups (n =6):control group (group C),depressed group (group D),and ketamine group (group K).Rats in groups D and K were insulted in the chronic unpredictable stress test for 21 d.On day 22,rats were injected with the same volume of saline (group C and group D) or ketamine 10 mg/kg (group K).The forced swimming test (FST) of 6 min was conducted and the immobility time of last 5 min was also recorded.Rats were then decapitated and the hippocampus was harvested to determine the levels of IL-1β,IDO,TRP,and KYN using an enzyme-linked immunosorbent assay.Results Compared with group C,the immobility time was increased in group D and group K (P〈 0.05 or P〈0.01).The contents of IL-1β,IDO,and TRP/KYN ratio were up-regulated in group D (P〈0.05).Compared with group D,the immobility time was decreased (P〈0.01) and the contents of IL-1β,IDO,and TRP/KYN ratio were down-regulated significantly in group K (P〈0.05).There was no significant difference between group C and group K.Conclusion The antidepressant effect of ketamine on rat is acting through down-regulating kynurenine pathway.
机构地区 [
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2014年第1期71-73,共3页 Journal of Clinical Anesthesiology
基金 国家自然科学基金(81271216) 全军“十二五”科研面上项目(CWS11J017)
关键词 氯胺酮 抑郁 炎症 犬尿素 吲哚胺2 3-二加氧酶 Ketamine Depression Inflammation Kynurenine IDO
  • 相关文献

参考文献13

  • 1Kessler RC,Berglund P,De mler 0,et al.The epidemiologyof major depressive disorder:results from the National Co-morbidity Survey Replication(NCS-R).JAMA,2003,289(23):3095-3105.
  • 2Li Nt Lee B,Liu RJ,et al.mTOR-dependent synapse forma-tion underlies the rapid antidepressant effects of NMDA an-tagonists,Science,2010,329(5994):959-964.
  • 3Li N,Liu RJ,Dwyer JM,et al.Glutamate N-methyl-D-as-partate receptor antagonists rapidly revense behavioral andsynaptic deficits caused by chronic stress exposure.Biol Psy-chiatry,2011,69(8):754-761.
  • 4Anisman H,Hayley S.Inflammatory factors contribute todepression and its comorbid conditions.Sci Signal,2012,5(244):45.
  • 5Eisenberger NI,Inagaki TK,Mashal NM,et al.Inflammationarid social experience:an inflammatory challer^e induces feelingsof social disconnection in addition to depressed mood Brain BehavImmun,2010,24(4):558-563.
  • 6SubJettecMB,Postolache TT.Neuroinflammationand depres-sion:the role of indoleamine 2,3-dioxygenase(IDO) as amolecular,pathway.Psychosom Med,2012,74(7):668-672.
  • 7Maes M,Leonard BE,Myint AM,et al.The new '5-HT'hypothesis of depression:cell-mediated immune activation in-duces indoleamine 2,3-dioxygenase,which leads to lowerplasma tryptophan and an increased synthesis of detrimentaltryptophan catabolites(TRYCATs),both of whichcontribute to the onset of depression.Prog Neuropsychophar-macol Biol Psychiatry,2011,35(3):702-721.
  • 8O'Connor JC,Lawson MA,Andre C.et al.Lipopolysaccha-ride-induced depressive-like behavior is mediated by in-doleamine 2,3-dioxygenase activation in mice.MolPsychiatry,2009,14(5):511-522.
  • 9O'Connor JC,Lawson MA,Andre C,et al.Induction ofIDO by Bacille Calmette-Guerin is responsible fordevelopment of murine depressive-like behavior.J Immunol,2009,182(5):3202-3012.
  • 10周志强,杨春,杨建军,徐建国.氯胺酮抗抑郁的研究进展[J].临床麻醉学杂志,2011,27(3):305-306. 被引量:18

二级参考文献21

  • 1Kessler RC,Berglund P,Demler O,et al.The epidemiology of major depressive disorder:results from the National Comorbidity Survey Replication (NCS-R).JAMA,2003,289:3095-3105.
  • 2Nakajima S,Suzuki T,Watanabe K,et al.Accelerating response to antidepressant treatment in depression:a review and clinical suggestions.Prog Neuropsychopharmacol Biol Psychiatry,2010,34:259-264.
  • 3Li N,Lee B,Liu RJ,et al.mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.Science,2010,329:959-964.
  • 4Machado-Vieira,Salvadore G,Diazgranados N,et al.Ketamine and the next generation of antidepressants with a rapid onset of action.Pharmacol Ther,2009,123:143-150.
  • 5san het Rot M,Collins KA,Murrough JW,et al.Safety and efficacy of repeated-dose intravenous ketamine for treatmentresistant depression.Biol Psychiatry,2010,67:139-145.
  • 6Messer M,Hailer W,Larson P,et al.The use of a series of ketamine infusions in two patients with treatment-resistant depression.J Neuropsychiatry Clin Neurosci,2010,22:442-444.
  • 7Baumbarger P,Muhlhauser M,Yang CR,et al.LY392098,a novel AMPA receptor potentiator:electrophysiological studies in prefrontal cortical neurons.Neuropharmacology,2001,40:992-1002.
  • 8Maeng S,Zarate CA Jr.The role of glutamate in mood disorders:results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects.Curr Psychiatry Rep,2007,9:467-474.
  • 9Pandey GN,Ren X,Rizavi HS,et al.Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims.Int J Neuropsychopharmacol,2008,11:1047-1061.
  • 10Castren E.Neurotrophic effects of antidepressant drugs.Curr Opin Pharmacol,2004,4:58-64.

共引文献17

同被引文献34

  • 1Gong,Li,Wang,et al.Targeting the Kynurenine pathway as a potential strategy to prevent and treat Alzheimer’s disease[J].Med Hypotheses,2011,77:383-385.
  • 2Greilberger,Fuchs,Leblhuber,et al.Carbonyl proteins as a clinical marker in Alzheimer’s disease and its relation to tryptophan degradation and immune activation[J].Clin Lab.2010,56:441-448.
  • 3Sublette,Postolache.Neuroinflammation and depression:The role of indoleamine 2,3-dioxygenase(IDO)as a molecular pathway[J].Psychosomatic Medicine,2012,74(7):668-672.
  • 4Elovainio,Hurme,Jokela,et al.Indoleamine 2,3-dioxygenase activation and depressive symptoms:Results from the young finns study Psychosomatic Medicine[J].2012,74(7):675–681.
  • 5O'Connor,Lawson,André,et al.Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice[J].Molecular Psychiatry,2009,14(5):511-522.
  • 6Corona,Norden,Skendelas,et al.Indoleamine 2,3-dioxygenase inhibitionattenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor(CX(3)CR1)-deficient mice[J].Brain Behavior,and Immunity,2012,26(6):964-968.
  • 7Howren,Lamkin,Suls.Associations of depression with Creactive protein,IL-1,and IL-6:A meta-analysis[J].Psychosomatic Medicine,2009,71(2):171–186.
  • 8Hughes,Carballedo,Mc Loughlin,et al.Tryptophan depletion in depressed patients occurs independentof kynurenine pathway activation[J].Brain,Behavior,and Immunity,2012,26(6):979-987.
  • 9Dowlati,Herrmann,Swardfager,et al.A meta-analysis ofcytokines in majordepression[J].Biological Psychiatry,2010,67(5),446-457.
  • 10Howren,Lamkin,Suls.Associations of depression with Creactive protein,IL-1 and IL-6:A meta-analysis[J].Psychosomatic Medicine,2009,71(2):171-186.

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部